- Home
- ATRA vs AIFF Comparison
ATRA vs AIFF Comparison
Compare ATRA & AIFF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATRA
- AIFF
- Stock Information
- Founded
- ATRA 2012
- AIFF 2006
- Country
- ATRA United States
- AIFF United States
- Employees
- ATRA N/A
- AIFF N/A
- Industry
- ATRA Biotechnology: Biological Products (No Diagnostic Substances)
- AIFF
- Sector
- ATRA Health Care
- AIFF
- Exchange
- ATRA Nasdaq
- AIFF NYSE
- Market Cap
- ATRA 40.1M
- AIFF 41.5M
- IPO Year
- ATRA 2014
- AIFF N/A
- Fundamental
- Price
- ATRA $7.94
- AIFF $2.74
- Analyst Decision
- ATRA Buy
- AIFF
- Analyst Count
- ATRA 5
- AIFF 0
- Target Price
- ATRA $17.75
- AIFF N/A
- AVG Volume (30 Days)
- ATRA 61.5K
- AIFF 1.4M
- Earning Date
- ATRA 08-11-2025
- AIFF 08-18-2025
- Dividend Yield
- ATRA N/A
- AIFF N/A
- EPS Growth
- ATRA N/A
- AIFF N/A
- EPS
- ATRA N/A
- AIFF N/A
- Revenue
- ATRA $199,732,000.00
- AIFF $139,000.00
- Revenue This Year
- ATRA N/A
- AIFF N/A
- Revenue Next Year
- ATRA N/A
- AIFF N/A
- P/E Ratio
- ATRA N/A
- AIFF N/A
- Revenue Growth
- ATRA 475.53
- AIFF N/A
- 52 Week Low
- ATRA $5.01
- AIFF $1.86
- 52 Week High
- ATRA $18.71
- AIFF $17.20
- Technical
- Relative Strength Index (RSI)
- ATRA 48.77
- AIFF 36.25
- Support Level
- ATRA $7.74
- AIFF $3.03
- Resistance Level
- ATRA $9.00
- AIFF $3.21
- Average True Range (ATR)
- ATRA 0.54
- AIFF 0.25
- MACD
- ATRA -0.12
- AIFF -0.04
- Stochastic Oscillator
- ATRA 19.79
- AIFF 3.74
About ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).
About AIFF FIREFLY NEUROSCIENCE INC
Firefly Neuroscience Inc is an AI company developing neuroscientific solutions that improve outcomes for patients with mental illnesses and cognitive disorders. It is focused on the commercialization of its Brain Network Analytics (BNA) software platform (the "BNA Platform")and the discovery and clinical development of biomarkers that support outcomes for people suffering from mental illnesses and cognitive disorders. The Company has one reportable segment: the BNA platform. The Company derives revenue from North America.